4-Hydroxybenzaldehyde

4-Hydroxybenzaldehyde

SCHEMBL7010903

Cc1c(O)cccc1C=O.Cc1cc(O)cc(C=O)c1.Cc1cc(O)ccc1C=O.O=Cc1ccc(O)cc1.O=Cc1ccccc1O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.39
TRIM33 Q9UPN9 2/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALDH5A1 P51649 1/20 0.35
ABAT P80404 1/20 0.35
TYR P14679 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
ERN1 O75460 2/20 0.32
CHRNA7 P36544 2/20 0.30
NPC1 O15118 1/20 0.30
PKM P14618 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10532733 0.85 CA1 (0.45) TRIM24TRIM33ALDH5A1ABATTYR
SCHEMBL9827652 0.82 ERN1 (0.43) TRIM24TRIM33ALDH5A1ABATTYR
4-Hydroxybenzaldehyde SCHEMBL7455404 0.76 TRIM24 (0.56) TRIM24TRIM33ALDH5A1ABATCA1
4-Hydroxybenzaldehyde SCHEMBL27623564 0.74 TRIM24 (0.55) TRIM24TRIM33ALDH5A1ABATCA1
4-Hydroxybenzaldehyde SCHEMBL4952623 0.74 TRIM24 (0.72) TRIM24TRIM33ALDH5A1ABATCA1
Hydroquinone SCHEMBL28407198 0.74 ERN1 (0.55) TRIM24TRIM33ALDH5A1ABATTYR
Salicyladehyde SCHEMBL7038124 0.73 TRIM24 (0.53) TRIM24TRIM33CYP1A2CYP2C19TYR
Metacresol SCHEMBL28223396 0.73 ACHE (0.57) TRIM24TRIM33CYP1A2CYP2C19TYR
Salicyladehyde SCHEMBL7034198 0.71 TRIM24 (0.62) TRIM24TRIM33CYP1A2CYP2C19TYR
Resorcinol SCHEMBL11728630 0.71 ERN1 (0.52) TRIM24TRIM33CYP1A2CYP2C19TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1267874-A2 THERAPEUTIC USES OF PPAR MEDIATORS Aventis Pharma Deutschland GmbH (DE) 2003-01-02 EP disclosed
WO-2001066098-A2 THERAPEUTIC USES OF PPAR MEDIATORS AVENTIS PHARMA DEUTSCHLAND GMBH 2001-09-13 WO disclosed